Fewer Delays. More Possibilities.
Bring precision and automation to therapy selection with RxLinQ - your AI-driven matchmaker for the latest FDA-approved treatments.
Smarter Therapy Alerts. Less Admin Burden.
RxLinQ automates the process of monitoring FDA approvals and matching patients to eligible therapies using advanced algorithms and CancerLinQ's deep oncology expertise. Embedded directly into your workflow, it reduces manual tracking, surfaces timely treatment opportunities, and allows teams to focus more on care and less on administration.
Key Benefits of RxLinQ
Reduced Admin Time
Automates therapy matching and alerts, freeing up staff to focus on patient care.
Improved Treatment Access
Connects patients to the newest therapies as soon as they're approved.
Built for Oncology
Designed by oncology experts to reflect the nuance of cancer care and biomarker-driven decision-making.
Integrated & Intelligent
Embedded in the workflow, RxLinQ quietly powers better care with timely, tailored insights.
Core Capabilities Driving Impact
Therapy-to-Patient Matching
Connect Patients to the Right Therapy
- Automatically scans patient profiles for match against newly approved therapies
- Surfaces both full and partial matches, including those needing follow-up testing
- Includes newly referred and established patients
- Designed to keep pace with fast-moving therapeutic landscapes
Automated Monitoring & Notifications
No More Manual Tracking
- Continuously monitors new drug approvals and label updates
- Instantly notifies care teams when a match is identified
- Reduces reliance on manual chart reviews or external alerts
- Helps practices stay current without the administrative overload
Cancer-Specific Matching Algorithms
Built for Oncology Precision
- Matches based on key physiologic and clinical factors
- Incorporates CancerLinQ’s oncology-derived matching logic
- Prioritizes accuracy and contextual relevance
- EHR-embedded for seamless integration with care team workflows
Genomic-Driven Alerts
Identify Testing Opportunities Earlier
- Highlights partial matches where additional biomarker or genomic testing could expand options
- Supports personalized medicine by prompting next-best testing or follow-up
- Drives earlier intervention and targeted therapy consideration
- Reduces missed opportunities for emerging treatments
Turning Data Into Decisions
How real-world comparisons guide more confident, personalized oncology care - right within the workflow.
New therapy alerts
automatically surface eligible patients within the EMR, ensuring no one is overlooked.
Patient match notifications
indicate when genomic testing could expand treatment options.
Real-time approvals monitoring
reduces the manual effort needed to keep up with fast-evolving oncology pipelines.
AI-driven matching
increases accuracy and consistency across care teams.
Workflow integration
enables physicians and staff to act without disrupting daily practice operations.